Aim. To analyze the efficiency of treatment and follow-up results of observation in patients who underwent cryodestruction for eyelid basalioma. Materials and methods. 30 patients with basalioma of eyelids were observed during the period of 2011-2013. Results. Out of 30 cases of neoplasms, there were 17 (56,6 %) ulcerous forms, 10 (33,3 %) - nodular, 3 (10,1 %) - superficial. By the stage of disease, dissemination of tumor process corresponded to T 1 N 0 M 0 in 4 (13 %) patients, T 2 N 0 M 0 - in 20 (67 %), T 3 N 0 M 0 - in 6 (20) patients. Cryodestruction of cancerous neoplasms of eyelids with carbonic acid snow was conducted. Relapse (continuous growth) of the nodular form T 3 N 0 M 0 localized on the lower eyelid was noted only in one (3,3 %) case of follow-up observation in 6 months. Conclusions. Cryodestruction using carbonic acid snow is an effective radical method for treatment of basal cell eyelid carcinoma; it is well survived by a patient.


  1. Анищенко И. С., Важенин А. В. Плоскоклеточный рак кожи (клиника, диагностика, лечение). Челябинск 2000; 144.
  2. Достижения и перспективы офтальмоонкологии: сб. тр. юбилейной научно-практической конф. МНИИ ГБ им. Гельмгольца. М. 2001; 9-28.
  3. Лихванцева В. Г., Анурова О. А. Опухоли век: клиника, диагностика, лечение. М.: ГЭОТАР-Медиа 2007; 447.
  4. Офтальмоонкология: руководство для врачей / под ред. А. Ф. Бровкиной. М.: Медицина 2002; 212.
  5. Bernstein S. C., Lim K. K., Brodland D. G. The many faces of squamous cell carcinoma. Dermatol. Surg. 1996; 22: 243-254.
  6. Buschmann W. A. Reappraisal of cryosurgery for eyelid basal cell carcinomas. Br. J. Ophthalmol. 2002; 86: 453-457.
  7. Loeffler M., Hornblass A. Characteristics and behavior of eyelid carcinoma. Ophthalmic. Surg. 1990; 21: 513-518.
  8. Mantovani E., Doro D., Milizia E., Steindler P. Reccurent eyelid basal cell carcinoma with sclerochoroidal infiltration: echographic findings. Ophthalmologica 1998; 212: 40-41.

Copyright (c) 2014 Borodina S.N., Devyatkova A.S., Subbotina I.N., Gavrilova T.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies